Medical Innovation Funding: Expert Support for Medical Companies
Medical innovation sits at the intersection of scientific rigour, regulatory complexity, and genuine commercial risk. It is also one of the most heavily supported areas of UK and European public funding. Programmes through Innovate UK, UKRI, and the National Institute for Health and Care Research (NIHR) collectively direct hundreds of millions of pounds each year towards medical companies developing genuinely transformative technologies — but competition is fierce and the quality bar is high.
OJB Consulting works with medical companies at all stages to identify the most suitable funding routes, build compelling grant applications, and submit proposals that stand up to expert assessment. With over £200 million in innovation funding secured across the life sciences and medical sectors, our team combines PhD-level writing expertise with a deep understanding of what assessors look for in a winning application.
What Our Medical Innovation Funding Consultancy Includes
We provide a fully managed, end-to-end service covering every stage of the funding process.
Funding landscape review — identifying the most appropriate Innovate UK, UKRI, NIHR, and international programmes for your specific medical innovation
Pre-qualification assessment — an honest internal review to confirm your project meets the eligibility, innovation, and commercial readiness criteria before we begin writing
Application strategy — structuring your narrative around clinical need, technical novelty, regulatory pathway, and commercial potential
PhD-level bid writing — expert proposal development that communicates complex medical science clearly and credibly to non-specialist assessors
Regulatory and clinical pathway alignment — ensuring your application reflects a credible route through MHRA, CE/UKCA marking, or relevant clinical development milestones
Submission management — final review, formatting, and submission to the relevant funding body
Post-submission support — feedback interpretation, scoring debrief, and resubmission guidance where relevant
Who This Service Is For
Our medical innovation funding support is designed for companies developing novel medical technologies, therapies, or services with a credible scientific basis and a clear route to market.
We work with:
Medical device companies developing Class I, IIa, IIb, or III devices seeking R&D or scale-up funding
In vitro diagnostic (IVD) developers bringing novel testing solutions to clinical or point-of-care markets
Pharmaceutical and biotech companies pursuing early-stage drug development, repurposing, or novel delivery mechanisms
Surgical technology and robotics businesses at proof-of-concept or pre-commercial stage
Digital health companies whose product has a regulated medical device or clinical decision support component
Academic spinouts and clinical entrepreneurs commercialising IP from NHS or university research settings
If your company is developing something with genuine medical or scientific novelty and a structured development roadmap, we can help you determine which funding routes are worth pursuing.
How the Process Works
1. Scoping Call
We start with a focused conversation about your technology, your development stage, and your funding goals. This allows us to assess fit quickly and identify the programmes most likely to be relevant for your pipeline.
2. Pre-Qualification
Before committing to a full application, we carry out a structured pre-qualification review. We assess your technology readiness level, evidence base, team capability, and commercial framing. If your project is not ready, we tell you clearly and explain what needs to be in place before applying.
3. Opportunity Mapping
We map the current landscape of medical funding competitions — including Innovate UK Smart Grants, NIHR i4i (Invention for Innovation), UKRI health and life sciences calls, SBRI Healthcare, and relevant international schemes — and recommend the most appropriate route for your project.
4. Application Development
Our PhD-level writers lead the proposal development process, working closely with your technical and clinical teams to capture the depth, nuance, and credibility that medical funding applications demand. We handle the scientific narrative, the clinical need case, the commercial model, and the impact assessment.
5. Review and Submission
Every application goes through a thorough internal quality review before submission, checking for consistency, alignment with competition guidance, and overall persuasiveness. We submit once we are satisfied it represents the strongest possible case.
Why Choose OJB Consulting
Over £200 million in innovation funding secured, with significant experience across medical devices, diagnostics, and life sciences
PhD-level writers with the scientific vocabulary to handle complex medical and clinical subject matter with authority
Deep understanding of Innovate UK, NIHR, UKRI, and SBRI processes — including the specific criteria assessors use to score applications
A rigorous pre-qualification process that means we only support applications we believe can succeed
Honest, expert guidance on regulatory pathway framing — a dimension many bid writers overlook and assessors scrutinise closely
Fully managed service that minimises the burden on your technical and clinical teams
The Value of Securing Medical Innovation Funding
For a medical company, grant funding is not just a source of capital — it is a validation signal. An Innovate UK award tells investors, NHS procurement teams, and clinical partners that an independent expert process has assessed your innovation and found it credible. That carries weight throughout your commercialisation journey.
Beyond validation, non-dilutive grant funding allows you to advance your clinical evidence or manufacturing readiness without sacrificing equity at a stage when your valuation may not yet reflect your potential. For medtech and pharma businesses, where development timelines are long and capital requirements are substantial, getting grants right early creates compounding commercial advantage.
Common Mistakes Medical Companies Make With Funding Applications
Underestimating the regulatory section
Many medical innovation applications are weakened by vague or incomplete regulatory pathway descriptions. Assessors in this sector understand MHRA processes, clinical trial phases, and UKCA marking requirements. An application that does not address the regulatory route clearly and credibly will struggle regardless of the quality of the underlying science.
Describing the technology rather than the innovation
Funders are not assessing how your device works — they are assessing whether it is genuinely novel, whether the approach is technically credible, and whether it addresses an unmet clinical need. Many applications spend too much space describing features and not enough explaining why existing solutions fall short.
Weak clinical evidence or needs framing
A strong medical funding application must demonstrate a clear and evidenced clinical need. Citing prevalence statistics is a start, but assessors want to understand the gap in current care, the limitations of existing interventions, and why this specific innovation is positioned to close that gap.
Applying to the wrong programme
Medical innovation spans multiple funding bodies and scheme types. A Phase 1 feasibility project, a pre-commercial device, and a scaling MedTech manufacturer will each suit different programmes. Applying to the wrong competition wastes time, damages your rejection history, and may close doors in future rounds.
Frequently Asked Questions
What types of medical innovation does OJB Consulting support?
We work across medical devices, IVDs, pharmaceutical innovation, surgical technology, clinical AI, and digital health with a regulated medical component. If your project involves scientific or technical novelty with a credible clinical application, we can assess its fundability.
Which grant programmes are most relevant for medical companies?
Key programmes include Innovate UK Smart Grants, NIHR i4i (Invention for Innovation), SBRI Healthcare, UKRI life sciences competitions, and the Biomedical Catalyst. For companies with international ambitions, Horizon Europe Health Cluster and the European Innovation Council are also worth considering.
Do you support companies at early feasibility stage or only later-stage development?
Both. Some of the most fundable medical innovation projects are at feasibility stage — Innovate UK and NIHR both offer specific programmes for early-stage development. What matters is that the scientific premise is credible and the team has the expertise to execute.
How do you handle the regulatory sections of a medical funding application?
We work with your regulatory lead or quality team to ensure the pathway framing is accurate, realistic, and appropriately detailed. Where clients do not have dedicated regulatory resource, we can help structure a credible regulatory narrative based on the device classification and development stage.
How long does a medical innovation funding application take to prepare?
Most applications require four to eight weeks from initial engagement to submission. NIHR and SBRI competitions can have specific formatting and timeline requirements that affect this. We provide a clear project timeline at the start of every engagement.
What makes a medical funding application stand out?
The strongest applications combine a clearly evidenced clinical need, technically credible innovation with demonstrable novelty, a realistic and well-costed development plan, and a coherent route to commercialisation. Assessors also look closely at team capability — your application must demonstrate that the people behind the project can deliver it.
Ready to Explore Medical Innovation Funding?
If your medical innovation has genuine scientific merit, a credible development roadmap, and the potential to improve patient outcomes, there is likely a grant programme that can support it. The first step is understanding which ones are right for your stage and your technology.
Book a scoping call with OJB Consulting today. We will review your project, give you an honest view of the funding landscape, and outline what it would take to build a winning application.